Policy | September 09, 2021
New law to regulate drugs and medical devices soon
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
The medicine is now approved for eight indications across five different types of cancer in China.
The World Health Organisation (WHO), has felt the need to conduct this training to build local capacities in poor countries to bridge the gap and enhance local production
TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research
Takeda is establishing the capability to manufacture TAK-019 (known outside Japan as NVX-CoV2373) at its facilities in Japan and aims to begin distribution in the early calendar year 2022
The company said Revital NXT is India’s first nutrition bar with the goodness of natural ginseng, 16 vitamins & minerals and triple blend protein
The company’s RenovoCath Delivery System designed for targeted treatment of solid tumours
In his previous assignment Perfetti was associated with Fabbrica Italiana Sintetici (F.I.S) as Chief Commercial Officer
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
First launched in 2005, pharmaREADY is a fully integrated, regulatory compliant, web-based platform to create, view, and manage global regulatory submissions
Subscribe To Our Newsletter & Stay Updated
